Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery
Aaron J. Courtenay(Queen's University Belfast), Ryan F. Donnelly(Queen's University Belfast), Maelíosa McCrudden(Queen's University Belfast), Emma McAlister(Queen's University Belfast), Etgar Levy‐Nissenbaum(Tel Aviv University), Nava Shterman(Teva Pharmaceuticals (Israel)), Lalitkumar K. Vora(Queen's University Belfast), Helen O. McCarthy(Queen's University Belfast), Mary‐Carmel Kearney(Queen's University Belfast), Galit Levin(Teva Pharmaceuticals (Israel)), Lilach Steiner(Teva Pharmaceuticals (Israel))
Cited by 155
Related Papers
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
|Pharmaceutics|2023|934
Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development
|Materials Science and Engineering R Reports|2016|926
Hydrogels for Hydrophobic Drug Delivery. Classification, Synthesis and Applications
|Journal of Functional Biomaterials|2018|292
Hollow microneedles: A perspective in biomedical applications
|International Journal of Pharmaceutics|2021|274